• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Evolving considerations for choice of hepatitis B vaccine
This article provides an overview of emerging considerations based on CDC recommendations and new clinical data around HBV vaccines, as well as the potential of Heplisav-B in fulfilling unmet needs that currently exist in the HBV prevention landscape.PMID:36787458 | DOI:10.37765/ajmc.2023.89325
Source: The American Journal of Managed Care - February 14, 2023 Category: Health Management Authors: Dalga D Surofchy Neil Shieh Iris Tam Source Type: research

Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations
Vaccine. 2021 May 21:S0264-410X(21)00582-X. doi: 10.1016/j.vaccine.2021.05.020. Online ahead of print.ABSTRACTThe hepatitis B virus is highly infectious and can cause incurable liver disease, leading to high morbidity rates, increased healthcare utilization, and high mortality. Multiple preventative hepatitis B vaccine options have been available for decades, but adherence to the traditional 6-month vaccine schedule for the approved 3-dose series remains low in adult populations at risk of hepatitis B exposure. A 2-dose hepatitis B vaccine (HEPLISAV-B) approved by the US Food and Drug Administration in 2017 induces rapid s...
Source: Vaccine - May 25, 2021 Category: Allergy & Immunology Authors: Alex Hirst Randall N Hyer Robert S Janssen Source Type: research